Logo

2012 Vol.30, N°4 - Suppl.73 - Table of contents

Treat-to-target in Rheumatoid Arthritis: Clinical and Pharmacoeconomic ConsiderationsTitle: Treat-to-target in Rheumatoid Arthritis: Clinical and Pharmacoeconomic Considerations

Guest Editors: G. Turchetti, J.S. Smolen, A. Kavanaugh, J. Braun, T. Pincus

PageArticle - [Author(s)]PDFAbs.
Treat-to-target in Rheumatoid Arthritis

CER6155
2012,30,4,Suppl.73
Pg. 0000

Treat-to-target in Rheumatoid Arthritis: Clinical and Pharmacoeconomic considerations
G. Turchetti, J. Smolen, A. Kavanaugh, J. Braun, T. Pincus › Free to View
Rheumatology ArticleRheumatology Abstract
Introduction

CER6149
2012,30,4,Suppl.73
Pg. 0001

Treat-to-target in rheumatoid arthritis: clinical and pharmacoeconomic considerations. Introduction
G. Turchetti, J. Smolen, A. Kavanaugh, J. Braun, T. Pincus, S. Bombardieri › Free to View
Rheumatology ArticleRheumatology Abstract
A. Clinical considerations

CER5985
2012,30,4,Suppl.73
Pg. 0002-0006

Treat-to-target: rationale and strategies
J. Smolen › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER5986
2012,30,4,Suppl.73
Pg. 0007-0009

Treat-to-target: measures
Y. Yazici › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER6031
2012,30,4,Suppl.73
Pg. 0010-0020

Treat-to-target: not as simple as it appears
T. Pincus, I. Castrejón, M. Bergman, Y. Yazici › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER5704
2012,30,4,Suppl.73
Pg. 0021-0026

Do we need guidelines to stop as well as to start biological therapies for rheumatoid arthritis?
M. van den Broek, W. Lems, C. Allaart › Free to View
Rheumatology ArticleRheumatology Abstract
B. Clinical trials

CER5987
2012,30,4,Suppl.73
Pg. 0027-0031

Long-term results of the FIN-RACo trial; treatment with a combination of traditional disease-modifying anti-rheumatic drugs is an excellent option in early rheumatoid arthritis
V. Rantalaiho, K. Puolakka, M. Korpela, P. Hannonen, T. Möttönen › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER5988
2012,30,4,Suppl.73
Pg. 0032-0034

Intensive management of early rheumatoid arthritis: the TICORA and TEAR studies
D. Porter › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER5706
2012,30,4,Suppl.73
Pg. 0035-0038

BeSt practice: the success of early-targeted treatment in rheumatoid arthritis
M. van den Broek, W. Lems, C. Allaart › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER5989
2012,30,4,Suppl.73
Pg. 0039-0043

The CAMERA (Computer-Assisted Management in Early Rheumatoid Arthritis) studies
J. Jacobs › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER6000
2012,30,4,Suppl.73
Pg. 0044-0049

The CIMESTRA study: intra-articular glucocorticosteroids and synthetic DMARDs in a treat-to-target strategy in early rheumatoid arhtritis
M. Hetland, K. Hørslev-Petersen › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER6026
2012,30,4,Suppl.73
Pg. 0050-0055

Patient self-report outcomes to guide a treat-to-target strategy in clinical trials and usual clinical care of rheumatoid arthritis
I. Castrejón, T. Pincus › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER5990
2012,30,4,Suppl.73
Pg. 0056-0063

Overview and analysis of treat-to-target trials in rheumatoid arthritis reporting on remission
M. Jurgens, P. Welsing, J. Jacobs › Free to View
Rheumatology ArticleRheumatology Abstract
C. Pharmacoeconomic considerations

CER6037
2012,30,4,Suppl.73
Pg. 0064-0071

The rationale of pharmacoeconomic analysis in rheumatologic indications
G. Turchetti, L. Scalone, O. Della Casa Alberighi, M. Mosca, S. Montella, P. Cortesi, L. Mantovani › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER6033
2012,30,4,Suppl.73
Pg. 0072-0084

Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis
G. Furneri, L. Mantovani, A. Belisari, M. Mosca, M. Cristiani, S. Bellelli, P. Cortesi, G. Turchetti › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER5991
2012,30,4,Suppl.73
Pg. 0085-0090

Payers` views on treating-to-target in rheumatoid arthritis: an English perspective
I. Scott, A. Wailoo, D. Scott › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER5995
2012,30,4,Suppl.73
Pg. 0091-0095

A clinician`s perspective on pharmacoeconomics and rheumatology
C. Thielscher › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER5994
2012,30,4,Suppl.73
Pg. 0096-0101

Interest of modelling in rheumatoid arthritis
A. Beresniak, D. Dupont, J. Becker, S. Merkesdal › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER5993
2012,30,4,Suppl.73
Pg. 0102-0106

Biosimilars in rheumatology: pharmacological and pharmacoeconomic issues
G. Lapadula, G. Ferraccioli › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER5992
2012,30,4,Suppl.73
Pg. 0107-0111

Critical analysis of economic tools and economic measurement applied to rheumatoid arthritis
M. Her, A. Kavanaugh › Free to View
Rheumatology ArticleRheumatology Abstract
D. Specific diseases

CER5996
2012,30,4,Suppl.73
Pg. 0112-0115

Treat-to-target in systemic lupus erythematosus: where are we today?
M. Mosca, D. Boumpas, I. Bruce, R. Cervera, L. Czirjak, T. Dörner, F. Houssiau, S. Jacobsen, M. Schneider, J. Smolen, A. Voskuyl, R. van Vollenhoven › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER6034
2012,30,4,Suppl.73
Pg. 0116-0122

Systemic lupus erythematosus and the economic perspective: a systematic literature review and points to consider
G. Turchetti, J. Yazdany, I. Palla, E. Yelin, M. Mosca › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER5997
2012,30,4,Suppl.73
Pg. 0123-0125

Psoriatic arthritis: treat-to-target
A. Kavanaugh › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER6036
2012,30,4,Suppl.73
Pg. 0126-0131

Systematic literature review on economic implications and pharmacoeconomic issues of psoriatic arthritis
P. Cortesi, L. Scalone, L. D'Angiolella, A. Belisari, F. Fusco, I. Olivieri, L. Mantovani › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER5998
2012,30,4,Suppl.73
Pg. 0132-0135

Axial spondyloarthritis: thoughts about nomenclature and treatment targets
J. Braun › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER6042
2012,30,4,Suppl.73
Pg. 0136-0141

A systematic literature review of the economic impact of ankylosing spondylitis
I. Palla, L. Trieste, C. Tani, R. Talarico, P. Cortesi, M. Mosca, G. Turchetti › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER5999
2012,30,4,Suppl.73
Pg. 0142-0144

Gout: thoughts about a treat-to-target programme
J. Braun, J. Smolen › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER6043
2012,30,4,Suppl.73
Pg. 0145-0148

The economic impact of gout: a systematic literature review
L. Trieste, I. Palla, F. Fusco, C. Tani, C. Baldini, M. Mosca, G. Turchetti › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER6030
2012,30,4,Suppl.73
Pg. 0149-0153

Treat-to-target in vasculitis: is this a sensible approach?
R. Luqmani › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER6044
2012,30,4,Suppl.73
Pg. 0154-0156

Systemic vasculitis: how little we know about their societal and economic burden
L. Trieste, I. Palla, C. Baldini, R. Talarico, L. D'Angiolella, M. Mosca, G. Turchetti › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER6014
2012,30,4,Suppl.73
Pg. 0157-0162

Toward a treat-to-target approach in the management of juvenile idiopathic arthritis
A. Consolaro, G. Negro, S. Lanni, N. Solari, A. Martini, A. Ravelli › Free to View
Rheumatology ArticleRheumatology Abstract
Continuing Medical Education Activity

CER6156
2012,30,4,Suppl.73
Pg. 0163-0169

Treat-to-target in Rheumatoid Arhritis: CME activity
No Author › Free to View
Rheumatology ArticleRheumatology Abstract